{
  "author": {
    "name": "David Fields",
    "webUrl": "/author/profile/david-fields/",
    "description": "",
    "imageLarge": "https://secure.gravatar.com/avatar/f16d6fc2845f417ea0e93a3f2b6cd37d?s=136&d=mm&r=g",
    "estimate": 1,
    "social": [],
    "articles": [
      {
        "uri": "/2021/12/29/regain-control-of-drug-spend-in-2022-3-pharmacy-benefits-trends-to-watch/",
        "title": "Regain control of drug spend in 2022: 3 pharmacy benefits trends to watch",
        "byline": "David Fields",
        "kicker": "Commentary",
        "prettyDate": "December 29, 2021",
        "timeToRead": "4 minute",
        "image": {
          "uri": "https://images.benefitspro.com/contrib/content/uploads/sites/412/2021/10/pill-money-investing-investments-health-pharma.jpg",
          "width": "616",
          "height": "411"
        },
        "authors": [
          {
            "webUrl": "/author/profile/david-fields/",
            "name": "David Fields"
          }
        ],
        "kickerNode": [
          {
            "uri": "/commentary/",
            "sectionName": "Commentary"
          }
        ],
        "summary": "Plan sponsors face yet another unpredictable year ahead.",
        "body": null
      }
    ]
  }
}